Technology Transfer

As the cell and gene therapy sector matures, technology transfer has become a pivotal step for pharmaceutical companies striving to advance from early-stage research to clinical development and large-scale commercial manufacturing. Whether transitioning preclinical methodologies to clinical production, or scaling for market supply, the technology transfer process presents inherent complexities that require strategic execution. As part of OXB’s CDMO services portfolio, we have developed a rigorous, phase-appropriate technology transfer framework tailored to meet the diverse needs of our clients. Our fit-for-purpose approach ensures the efficient transfer of processes and technical expertise while maintaining the highest quality standards and accelerated timelines. Our adaptable approach means clients are supported at every phase of development, whether they need early phase technical support, GMP manufacturing or commercial scale up.